Genetically Targeted Enzyme Replacement Therapy (high-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Targeted Enzyme Replacement Therapy (high-dose), covering 2017-01-31 to 2017-01-31. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure [Phase 1, Phase 2]